Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bispecific Antibodies in the Treatment of Hematologic Malignancies.
Clin Pharmacol Ther. 2019 Oct;106(4):781-791. doi: 10.1002/cpt.1396. Epub 2019 Mar 29.
Clin Pharmacol Ther. 2019.
PMID: 30770546
Free PMC article.
Review.
Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia.
Topp MS, Gökbuget N, Zugmaier G, Klappers P, Stelljes M, Neumann S, Viardot A, Marks R, Diedrich H, Faul C, Reichle A, Horst HA, Brüggemann M, Wessiepe D, Holland C, Alekar S, Mergen N, Einsele H, Hoelzer D, Bargou RC.
Topp MS, et al. Among authors: alekar s.
J Clin Oncol. 2014 Dec 20;32(36):4134-40. doi: 10.1200/JCO.2014.56.3247. Epub 2014 Nov 10.
J Clin Oncol. 2014.
PMID: 25385737
Clinical Trial.
Item in Clipboard
Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia.
Zugmaier G, Topp MS, Alekar S, Viardot A, Horst HA, Neumann S, Stelljes M, Bargou RC, Goebeler M, Wessiepe D, Degenhard E, Gökbuget N, Klinger M.
Zugmaier G, et al. Among authors: alekar s.
Blood Cancer J. 2014 Sep 5;4(9):244. doi: 10.1038/bcj.2014.64.
Blood Cancer J. 2014.
PMID: 25192414
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.
Reardon DA, Desjardins A, Rixe O, Cloughesy T, Alekar S, Williams JH, Li R, Taylor CT, Lassman AB.
Reardon DA, et al. Among authors: alekar s.
Invest New Drugs. 2020 Dec;38(6):1784-1795. doi: 10.1007/s10637-020-00950-1. Epub 2020 May 20.
Invest New Drugs. 2020.
PMID: 32436060
Clinical Trial.
Item in Clipboard
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors.
Maitland ML, Sachdev JC, Sharma MR, Moreno V, Boni V, Kummar S, Stringer-Reasor E, Lakhani N, Moreau AR, Xuan D, Li R, Powell EL, Jackson-Fisher A, Bowers M, Alekar S, Xin X, Tolcher AW, Calvo E.
Maitland ML, et al. Among authors: alekar s.
Clin Cancer Res. 2021 Aug 15;27(16):4511-4520. doi: 10.1158/1078-0432.CCR-20-3757. Epub 2021 Jun 3.
Clin Cancer Res. 2021.
PMID: 34083232
Free PMC article.
Item in Clipboard
Serum magnesium in tetanus.
Natu MN, Sapatnekar SM, Alekar SV.
Natu MN, et al. Among authors: alekar sv.
Indian J Med Sci. 1980 Feb;34(2):24-6.
Indian J Med Sci. 1980.
PMID: 7419265
No abstract available.
Item in Clipboard
Cite
Cite